By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Northwest Biotherapeutics, Inc. 

21720 23rd Drive SE
Suite 100
Bothell  Washington  98021  U.S.A.
Phone: 425-608-3000-or-877-606-9246-Toll-Free Fax: 425-608-3026




Cytogen Corporation  Development of ex vivo prostate cancer immunotherapy

Company News
NW Bio (NWBO) Announces A Registered Direct Offering Of $3.7 Million With New Institutional Investors 7/5/2016 7:52:38 AM
NW Bio (NWBO) Enters First 180-Day Grace Period Relating To Non-Compliance With Nasdaq $1.00 Per Share Bid Requirement 7/1/2016 6:30:54 AM
A Look into NW Bio (NWBO)'s Downfall: Bad Management or Short Sellers? 6/24/2016 7:01:08 AM
NW Bio (NWBO) Announces Scientific Advisory Board 6/13/2016 10:35:50 AM
NW Bio (NWBO) Announces Operations Updates 5/3/2016 9:24:32 AM
NW Bio (NWBO) Announces Registered Direct Offering Of Up To $27.6 Million With Existing Institutional Investors 2/29/2016 9:40:01 AM
Comments by Principal Investigator the Real Reason NW Bio (NWBO)'s Stock Tanked Last Fall 2/10/2016 7:28:44 AM
NW Bio (NWBO) Announces Appointment Of Two New Independent Directors With Biotech/Pharma Expertise and Cybersecurity/Investigations Expertise 1/25/2016 7:53:24 AM
NW Bio (NWBO) Presenting At Phacilitate Immunotherapy World Forum 1/25/2016 7:35:32 AM
NW Bio (NWBO) Issues Statement On Adverse Market Conditions And NW Bio Stock Decline 1/8/2016 8:09:26 AM